ArticleInternational journal of cancer2026

Real-world efficacy and toxicity of ipilimumab and nivolumab as a first-line treatment for advanced renal cell carcinoma according to IMDC risk criteria-A multi-center retrospective analysis on behalf of the GUARDIANS group.

Hendrik Dinkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.